3-(4-Hydroxy-2-oxabutyl)-8-nonyloxy-1,3-diaza-2-oxophenoxazine

ID: ALA4862620

PubChem CID: 164623124

Max Phase: Preclinical

Molecular Formula: C22H31N3O5

Molecular Weight: 417.51

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCOc1ccc2c(c1)Nc1nc(=O)n(COCCO)cc1O2

Standard InChI:  InChI=1S/C22H31N3O5/c1-2-3-4-5-6-7-8-12-29-17-9-10-19-18(14-17)23-21-20(30-19)15-25(22(27)24-21)16-28-13-11-26/h9-10,14-15,26H,2-8,11-13,16H2,1H3,(H,23,24,27)

Standard InChI Key:  OSAGFUWFEGXOHJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
   15.4692  -22.6455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4680  -23.4729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8964  -22.6418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1811  -22.2328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8993  -23.4724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1817  -23.8868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1817  -24.7110    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6170  -23.8822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6154  -24.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8970  -25.1300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8994  -25.9562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6184  -26.3713    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3367  -25.9539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3360  -25.1214    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0519  -26.3650    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6196  -27.1963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3346  -27.6078    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0485  -27.1943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7635  -27.6057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4774  -27.1922    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1786  -21.4078    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8918  -20.9932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6076  -21.4035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3207  -20.9889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0365  -21.3993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7497  -20.9846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4654  -21.3950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1786  -20.9803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8943  -21.3907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6075  -20.9761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  6  1  0
  5  3  1  0
  3  4  2  0
  4  1  1  0
  5  6  2  0
  5  8  1  0
  6  7  1  0
  7 10  1  0
  9  8  1  0
  9 10  1  0
  9 14  2  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 12 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  4 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4862620

    ---

Associated Targets(Human)

HEL (6614 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human alphaherpesvirus 3 (4092 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human betaherpesvirus 5 (5122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.51Molecular Weight (Monoisotopic): 417.2264AlogP: 4.19#Rotatable Bonds: 13
Polar Surface Area: 94.84Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.52CX LogD: 3.52
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.40Np Likeness Score: -0.21

References

1. Kozlovskaya LI, Volok VP, Shtro AA, Nikolaeva YV, Chistov AA, Matyugina ES, Belyaev ES, Jegorov AV, Snoeck R, Korshun VA, Andrei G, Osolodkin DI, Ishmukhametov AA, Aralov AV..  (2021)  Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses.,  220  [PMID:33894564] [10.1016/j.ejmech.2021.113467]

Source